Status:
COMPLETED
Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
Lead Sponsor:
Emory University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Vaccination
Eligibility:
FEMALE
13-18 years
Phase:
PHASE3
Brief Summary
African American adolescent females seeking treatment for STIs are an underserved population at increased risk for HPV infection. While GARDASIL is an effective preventive vaccine, vaccination rates a...
Eligibility Criteria
Inclusion
- African American
- Female
- Age 13-18 years
- Seeking reproductive/STI services at participating clinic
- Ability to give written informed consent or assent
Exclusion
- Pregnant
- Married
- Already received the HPV vaccine
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT00813319
Start Date
October 1 2009
End Date
March 1 2014
Last Update
August 12 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fulton County Department of Health and Wellness
Atlanta, Georgia, United States, 30303
2
DeKalb County Health Department
Decatur, Georgia, United States, 30034